157 related articles for article (PubMed ID: 11925119)
21. In vitro activity of human chorionic gonadotropin (hCG)--doxorubicin conjugates against ovarian cancer cells.
Beck EP; Vincenti D; Licht P; Berkholz A; Jäger W; Lang N; Merkle E
Anticancer Res; 2000; 20(5A):3001-6. PubMed ID: 11062714
[TBL] [Abstract][Full Text] [Related]
22. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of human chorionic gonadotropin causes multiple reproductive defects in transgenic mice.
Matzuk MM; DeMayo FJ; Hadsell LA; Kumar TR
Biol Reprod; 2003 Jul; 69(1):338-46. PubMed ID: 12672665
[TBL] [Abstract][Full Text] [Related]
24. Regulation of the angiopoietin-2 gene by hCG in ovarian cancer cell line OVCAR-3.
Pietrowski D; Wiehle P; Sator M; Just A; Keck C
Horm Metab Res; 2010 May; 42(5):328-33. PubMed ID: 20213583
[TBL] [Abstract][Full Text] [Related]
25. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract][Full Text] [Related]
26. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
Lindner DJ; Borden EC; Kalvakolanu DV
Clin Cancer Res; 1997 Jun; 3(6):931-7. PubMed ID: 9815768
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.
Kioi M; Kawakami M; Shimamura T; Husain SR; Puri RK
Cancer; 2006 Sep; 107(6):1407-18. PubMed ID: 16902988
[TBL] [Abstract][Full Text] [Related]
28. Growth regulation effects of gonadotropin induced steroidogenic response in human ovarian cancer.
Kraemer S; Jaeger WH; Lang N
Anticancer Res; 2001; 21(3B):2005-10. PubMed ID: 11497290
[TBL] [Abstract][Full Text] [Related]
29. Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells.
Choi JH; Choi KC; Auersperg N; Leung PC
Endocr Relat Cancer; 2006 Jun; 13(2):641-51. PubMed ID: 16728589
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
Elgqvist J; Andersson H; Bäck T; Hultborn R; Jensen H; Karlsson B; Lindegren S; Palm S; Warnhammar E; Jacobsson L
J Nucl Med; 2005 Nov; 46(11):1907-15. PubMed ID: 16269606
[TBL] [Abstract][Full Text] [Related]
31. Antitumor effects of interferon-omega: in vivo therapy of human tumor xenografts in nude mice.
Horton HM; Hernandez P; Parker SE; Barnhart KM
Cancer Res; 1999 Aug; 59(16):4064-8. PubMed ID: 10463608
[TBL] [Abstract][Full Text] [Related]
32. GnRH agonist therapy in human ovarian epithelial carcinoma (OVCAR-3) heterotransplanted in the nude mouse is characterized by latency and transience.
Peterson CM; Jolles CJ; Carrell DT; Straight RC; Jones KP; Poulson AM; Hatasaka HH
Gynecol Oncol; 1994 Jan; 52(1):26-30. PubMed ID: 8307497
[TBL] [Abstract][Full Text] [Related]
33. Expression and secretion of the beta subunit of human chorionic gonadotropin by bladder carcinoma in vivo and in vitro.
Nishimura R; Koizumi T; Morisue K; Yamanaka N; Lalwani R; Yoshimura M; Nakagawa T; Shii K; Hasegawa K; Baba S
Cancer Res; 1995 Apr; 55(7):1479-84. PubMed ID: 7882356
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a xenograft model of human ovarian carcinoma which produces ascites and intraabdominal carcinomatosis in mice.
Hamilton TC; Young RC; Louie KG; Behrens BC; McKoy WM; Grotzinger KR; Ozols RF
Cancer Res; 1984 Nov; 44(11):5286-90. PubMed ID: 6333272
[TBL] [Abstract][Full Text] [Related]
35. Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system.
Günthert AR; Gründker C; Bongertz T; Schlott T; Nagy A; Schally AV; Emons G
Am J Obstet Gynecol; 2004 Oct; 191(4):1164-72. PubMed ID: 15507937
[TBL] [Abstract][Full Text] [Related]
36. Antitumor activity of 4-(N-hydroxyphenyl)retinamide conjugated with poly(L-glutamic acid) against ovarian cancer xenografts.
Zou C; Brewer M; Cao X; Zang R; Lin J; Deng Y; Li C
Gynecol Oncol; 2007 Dec; 107(3):441-9. PubMed ID: 17854871
[TBL] [Abstract][Full Text] [Related]
37. Follicle-stimulating hormone peptide can facilitate paclitaxel nanoparticles to target ovarian carcinoma in vivo.
Zhang XY; Chen J; Zheng YF; Gao XL; Kang Y; Liu JC; Cheng MJ; Sun H; Xu CJ
Cancer Res; 2009 Aug; 69(16):6506-14. PubMed ID: 19638590
[TBL] [Abstract][Full Text] [Related]
38. Human chorionic gonadotropin suppresses human breast cancer cell growth directly via p53-mediated mitochondrial apoptotic pathway and indirectly via ovarian steroid secretion.
Yuri T; Kinoshita Y; Emoto Y; Yoshizawa K; Tsubura A
Anticancer Res; 2014 Mar; 34(3):1347-54. PubMed ID: 24596382
[TBL] [Abstract][Full Text] [Related]
39. Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice.
Pourgholami MH; Yan Cai Z; Lu Y; Wang L; Morris DL
Clin Cancer Res; 2006 Mar; 12(6):1928-35. PubMed ID: 16551879
[TBL] [Abstract][Full Text] [Related]
40. Highly purified müllerian inhibiting substance inhibits human ovarian cancer in vivo.
Stephen AE; Pearsall LA; Christian BP; Donahoe PK; Vacanti JP; MacLaughlin DT
Clin Cancer Res; 2002 Aug; 8(8):2640-6. PubMed ID: 12171896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
